Oxidative Stress, Central Hypothyroidism, Autism and You
Warsaw University of Life Sciences, Source: Wikipedia
Regular readers of this blog will have noticed there are some strange things going on related to endocrinology in the autistic brain; in effect there are low levels of certain critical hormones.
We saw in research from the Harvard Medical School that it seemed that oxidative stress in the brain affected the level of a key enzyme D2 (iodothyronine deiodinase type 2). D2 has an important role; it converts the passive thyroid pro-hormone T4, into the active thyroid hormone T3. Without enough T3, you are said to be hypothyroid. When the brain is affected, it is called central hypothyroidism.
As T3 is essential for cellular metabolism, growth and differentiation, and thus critical for brain development, thyroid deficiency during embryonic or early postnatal periods would likely lead to developmental abnormalities, including autism.
Now we have some follow up research from Harvard and Warsaw University. The paper is more readable than many scientific papers, so click on the full version below.
“While the mechanism responsible for the decrease in brain T3 levels in ASD is unclear, the relationship between T3 and Hg (mercury) should not be that easily dismissed.
Our recent animal study of perinatal mercury exposure in rats supports the possibility that the environmental toxicants can affect brain deiodinases and thus affect brain TH (thyroid hormone) status even in absence of systemic hormonal deregulation
Total Hg levels were determined in human postmortem cerebellar and brain stem samples derived from both male and female ASD cases. The results of this analysis, presented in Fig. 4 as the male and female combined data, indicate no significant difference in Hg levels between control and ASD cases in either the brainstem or the cerebellar samples.
Thus, changes in oxidative stress levels reported here could also modulate D2 activity. It is of interest that TH regulates GSH levels in the developing brain and treatment of astrocyte cultures with TH results in increased GSH levels and improved antioxidant defense, suggesting that TH plays a positive role in maintaining GSH homeostasis and protecting the brain from oxidative stress. Thus lower T3 levels in ASD brain may exacerbate the oxidative stress.
The results presented here suggest that putamen is the brain region that exhibits not only an increase in oxidative stress and a decrease in T3 levels, but also most prominent changes in gene expression in ASD. Interestingly, the putamen's main function is to regulate movements and influence reinforcement and implicit learning, processes that rely on interaction with the environment; abnormal sensory reactions are part of autistic pathology. Thus, present study further implicates this brain region in autistic pathology.
Decreased brain TH levels and changes in gene expression in ASD brains, suggested by the present study, are likely to impact the developing brain and have clinical implications. It has been previously observed that deficiency of T3 during early postnatal periods impacts basic stages of development i.e. neurogenesis, cell migration of, and synaptogenesis that could contribute to downstream functional and structural damages observed in ASD brains. At this point, because the instability of D2 in the postmortem tissue and lack of detectable D3 activity we can only speculate on the molecular mechanisms involved in decreased TH in ASD brains. However, present data suggest that the role of TH in ASD pathology should not be dismissed prematurely and certainly requires further study, especially since correction of TH deficiency may offer new therapies.
Our results showed, for the first time, brain region-specific decrease in TH levels in the cortical regions of ASD male cases. Data reported here, although derived from a limited sample size, suggest the possibility of brain region-specific disruption of TH homeostasis in autistic brain. Furthermore, brain region-specific changes in TH-dependent gene expression reported here suggest disruption of gene expression that could possibly impact the developing brain and contribute to the autistic pathology. While the postmortem instability of brain deiodinases precluded further molecular studies, the role of TH in ASD pathology and TH-based new therapies warrant future studies.
The expression of several thyroid hormone (TH)-dependent genes was altered in ASD. Data reported here suggest the possibility of brain region-specific disruption of TH homeostasis and gene expression in autism. “
Conclusion
We know that T3 is reduced in the autistic brain. This may be because oxidative stress has reduced the level of the enzyme D2, but we cannot be sure, because the brain samples are old and D2 will decay with time.
The authors clearly hope that thyroid hormone-based therapies for autism will emerge. Autistic people are likely to be euthyroid, so in their blood the thyroid levels are just fine; it is just in the brain the level of T3 is low. A successful therapy would raise the level of T3 in the brain, without affecting the level of T3 in the blood.
Reducing oxidative stress (if present) can only do good. This is easily done with N-acetylcysteine (NAC). If giving NAC reduces stimming/stereotypy, then the odds are that you have oxidative stress. Oxidative stress appears to be chronic, it never goes away; you can treat it, but you cannot cure it. We also saw this is the asthma research, where smokers were resistant to asthma drugs. Even decades after ceasing to smoke, oxidative stress lingered and reduced the effectiveness of drugs. In asthma the treatment for oxidative stress is NAC.
If you want a diagnostic test to establish central hypothyroidism (without any injections), this is easy. Just give a small dose of T3 for a few days. Before the thyroid has time to reduce its natural thyroid output, there will be a temporary increase in brain T3 levels. If behavior improves notably for a day or two and then reverts, you have established a case of central hypothyroidism and seen how it affects behavior.
The scientific method of determining central hypothyroidism uses a test called the TRH stimulation test; but you do not get to see how behavior changes when T3 increases in the brain.
Also, note again that while mercury is definitely very bad for you, the study showed that the brains of people with autism had no more mercury than the control group.
We also see that while oxidative stress may cause a reduction in brain T3 levels, low T3 levels promote further oxidative stress. So it is a self-perpetuating process. This brings us back again to my venn diagram, where everything is inter-related.
Comments
Post a Comment